Your browser doesn't support javascript.
loading
SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex.
Feng, Yongmei; Pinkerton, Anthony B; Hulea, Laura; Zhang, Tongwu; Davies, Michael A; Grotegut, Stefan; Cheli, Yann; Yin, Hongwei; Lau, Eric; Kim, Hyungsoo; De, Surya K; Barile, Elisa; Pellecchia, Maurizio; Bosenberg, Marcus; Li, Jian-Liang; James, Brian; Hassig, Christian A; Brown, Kevin M; Topisirovic, Ivan; Ronai, Ze'ev A.
Afiliación
  • Feng Y; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Pinkerton AB; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Hulea L; Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montréal, Canada. Department of Oncology, McGill University, Montréal, Canada.
  • Zhang T; Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, NCI, Bethesda, Maryland.
  • Davies MA; Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Grotegut S; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Cheli Y; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Yin H; Cancer and Cell Biology Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona.
  • Lau E; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Kim H; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • De SK; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Barile E; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Pellecchia M; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Bosenberg M; Departments of Dermatology and Pathology, Yale University, School of Medicine, New Haven, Connecticut.
  • Li JL; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • James B; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Hassig CA; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Brown KM; Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, NCI, Bethesda, Maryland.
  • Topisirovic I; Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montréal, Canada. Department of Oncology, McGill University, Montréal, Canada.
  • Ronai ZA; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. zeev@ronailab.net.
Cancer Res ; 75(24): 5211-8, 2015 Dec 15.
Article en En | MEDLINE | ID: mdl-26603897
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quinolonas / Factor 4F Eucariótico de Iniciación / Proliferación Celular / Lactamas / Melanoma / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quinolonas / Factor 4F Eucariótico de Iniciación / Proliferación Celular / Lactamas / Melanoma / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos